ASAN Medical Center Aortic Valve Replacement Registry
ASAN-AVR
1 other identifier
observational
900
1 country
1
Brief Summary
This study evaluates the effectiveness and safety of surgical aortic valve replacement and transcatheter aortic valve replacement in aortic Stenosis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Dec 2017
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 21, 2017
CompletedFirst Posted
Study publicly available on registry
October 2, 2017
CompletedStudy Start
First participant enrolled
December 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 15, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2027
ExpectedJanuary 2, 2026
December 1, 2025
5.6 years
September 21, 2017
December 28, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
All cause death
1 year
Secondary Outcomes (16)
Cardiovascular mortality
1,6 and 12 months and 5 years
Cardiovascular mortality
1,6 and 12 months and 5 years
Myocardial infarction
1,6 and 12 months and 5 years
Stroke
1,6 and 12 months and 5 years
Bleeding
1,6 and 12 months and 5 years
- +11 more secondary outcomes
Study Arms (1)
all aortic stenosis
Interventions
All patients who underwent transcatheter aortic valve replacement in Asan medical center, republic of Korea
All patients who underwent surgical aortic valve replacement in Asan medical center, republic of Korea
Eligibility Criteria
All successful transcatheter aortic valve replacement or surgical aortic valve replacement
You may qualify if:
- All successful transcatheter aortic valve replacement or surgical aortic valve replacement
- Written consent
You may not qualify if:
- Infective endocarditis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Ho-Jin Kimlead
- CardioVascular Research Foundation, Koreacollaborator
Study Sites (1)
Asan Medical Hospital
Seoul, South Korea
Related Publications (3)
Kim HJ, Kang DY, Park H, Ahn JM, Kim JB, Kim SO, Ok YJ, Lee SH, Pyo WK, Ko E, Lee SA, Kim DH, Park SJ, Park DW, Choo SJ. Comparison of Sutureless Bioprosthetic Valve With Surgical or TAVR for Severe Aortic Stenosis. JACC Asia. 2021 Oct 26;1(3):317-329. doi: 10.1016/j.jacasi.2021.08.007. eCollection 2021 Dec.
PMID: 36341221DERIVEDYang Y, Ahn JM, Kang DY, Ko E, Kim S, Kim TO, Kim JH, Lee J, Lee SA, Kim DH, Kim HJ, Kim JB, Choo SJ, Park SJ, Park DW. Implication of Different ECG Left Ventricular Hypertrophy in Patients Undergoing Transcatheter Aortic Valve Replacement. J Am Heart Assoc. 2022 Feb 15;11(4):e023647. doi: 10.1161/JAHA.121.023647. Epub 2022 Feb 3.
PMID: 35112886DERIVEDJeong YJ, Ahn JM, Kang DY, Park H, Ko E, Kim HJ, Kim JB, Choo SJ, Lee SA, Park SJ, Kim DH, Park DW. Incidence, Predictors, and Prognostic Impact of Immediate Improvement in Left Ventricular Systolic Function After Transcatheter Aortic Valve Implantation. Am J Cardiol. 2021 Aug 1;152:99-105. doi: 10.1016/j.amjcard.2021.04.037. Epub 2021 Jun 11.
PMID: 34127247DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Seung-jung Park, MD
Asan Medical Center
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
September 21, 2017
First Posted
October 2, 2017
Study Start
December 1, 2017
Primary Completion
July 15, 2023
Study Completion (Estimated)
July 1, 2027
Last Updated
January 2, 2026
Record last verified: 2025-12